127 related articles for article (PubMed ID: 945124)
1. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
Hohorst HJ; Peter G; Struck RF
Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
[TBL] [Abstract][Full Text] [Related]
2. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
Takamizawa A; Iwata T; Yamaguchi K; Shiratori O; Harada M
Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
Kutscher B; Niemeyer U; Engel J; Kleemann A; Hilgard P; Pohl J; Scheffler G
Arzneimittelforschung; 1995 Mar; 45(3):323-6. PubMed ID: 7741794
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
Takamizawa A; Matsumoto S; Iwata T; Makino I
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):1877-91. PubMed ID: 562722
[No Abstract] [Full Text] [Related]
5. Mass spectrometric characterization of activated N-(2-chloroethyl)amino oxazaphosphorine derivative.
Przybylski M; Ringsdorf H; Lenssen U; Peter G; Voelcker G; Wagner T; Hohorst HJ
Biomed Mass Spectrom; 1977 Aug; 4(4):209-15. PubMed ID: 912018
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
Paprocka M; Kuśnierczyk H; Budzyński W; Rak J; Radzikowski C
Arch Immunol Ther Exp (Warsz); 1986; 34(3):275-84. PubMed ID: 3592931
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
Misiura K; Kinas RW; Stec WJ; Kusnierczyk H; Radzikowski C; Sonoda A
J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide.
Struck RF; Schmid SM; Waud WR
Cancer Chemother Pharmacol; 1994; 34(3):191-6. PubMed ID: 8004750
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.
Takamizawa A; Matsumoto S; Iwata T; Makino I; Yamaguchi K; Uchida N; Kasai H; Shiratori O; Takase S
J Med Chem; 1978 Feb; 21(2):208-14. PubMed ID: 621716
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
Phillips OA; Nelson LA; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
[TBL] [Abstract][Full Text] [Related]
11. Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
Lelieveld P; van Putten LM
Cancer Treat Rep; 1976 Apr; 60(4):373-9. PubMed ID: 1064468
[TBL] [Abstract][Full Text] [Related]
12. [Studies on cytostatic effect of oxazophosphorine metabolites. Role of phospho- and phosphoramide mustards; practical implications].
Hładoń B
Acta Pol Pharm; 1982; 39(1-3):185-8. PubMed ID: 7180550
[No Abstract] [Full Text] [Related]
13. [Quantitative determination of cyclophosphamide, ifosfamide, and trofosfamide and their stable metabolites on TLC-plates with the aid of 4-pyridine-aldehyde-2-benzothiazolyl-hydrazone (PBH) (author's transl)].
Norpoth K; Addicks HW; Witting U; Mŭller G; Raidt H
Arzneimittelforschung; 1975 Sep; 25(9):1331-6. PubMed ID: 1242654
[TBL] [Abstract][Full Text] [Related]
14. X-ray crystallographic studies of cyclophosphamide (NSC-26271) derivatives.
Camerman A; Smith HW; Camerman N
Cancer Treat Rep; 1976 Apr; 60(4):517-22. PubMed ID: 1277229
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationships of pre-activated analogs of cyclophosphamide (NSC-26271).
Montgomery JA; Struck RF
Cancer Treat Rep; 1976 Apr; 60(4):381-93. PubMed ID: 945126
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of optical isomers of cyclophosphamide, ifosfamide and trofosfamide as compared to clinically used racemates.
Kuśnierczyk H; Radzikowski C; Paprocka M; Budzyński W; Rak J; Kinas R; Misiura K; Stec W
J Immunopharmacol; 1986; 8(4):455-80. PubMed ID: 3805744
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumour activity of stereoisomers of 4-hydroperoxy derivatives of ifosfamide and its bromo analogue.
Misiura K; Szymanowicz D; Kusnierczyk H; Wietrzyk J; Opolski A
Farmaco; 2002 Apr; 57(4):315-9. PubMed ID: 11989810
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy of 6-thioguanine with various antitumor agents against murine leukemia L-1210.
Fujimoto S; Inagaki J; Horikoshi N; Hoshino A
Gan; 1977 Oct; 68(5):543-52. PubMed ID: 201534
[TBL] [Abstract][Full Text] [Related]
19. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
Benckhuysen C; van der Steen J; Spanjersberg EJ
Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide- or ifosfamide-treated L 1210 leukaemia cells: immunogenicity, viability and metabolism.
Skórski T; Kawalec M; Hoser G
Folia Biol (Praha); 1986; 32(5):354-65. PubMed ID: 3506526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
